手阳明经透刺治疗桥本甲状腺炎的探索性随机对照试验
本探索性随机对照试验纳入58例桥本甲状腺炎患者,1:1随机分为手阳明经透刺组与等待治疗组,针刺组接受16周治疗并随访16周。结果显示两组甲状腺过氧化物酶抗体变化无统计学差异,但针刺组甲状腺球蛋白抗体水平显著低于等待组,且ThyPRO-39与SF-36评分组间有统计学差异,HADS无差异。提示该针刺法可能安全可行,有助于改善症状并降低TGab水平。
要点
- 手阳明经透刺可能降低桥本甲状腺炎患者TGab水平并改善生活质量。
- 两组TPOab变化及HADS评分未见统计学差异。
- 该疗法在桥本甲状腺炎甲减患者中可能安全可行。
核心结论
- 手阳明经透刺对桥本甲状腺炎甲减患者可能安全可行,有助于改善症状并降低TGab水平。
研究设计与样本
- 探索性随机对照试验,纳入58例受试者,按1:1随机分为针刺组与等待治疗组。
- 针刺组接受16周针刺治疗,随后16周随访观察;等待组接受16周甲状腺素补充,随后16周补偿治疗。
主要发现
- 治疗16周后,两组TPOab水平变化无统计学差异。
- 针刺组TGab水平显著低于等待组,差异为-141.97(95%CI:-222.4至-61.5),P=0.011。
- 两组ThyPRO-39总分与SF-36总分有统计学差异(P ThyPRO-39<0.001,P SF-36=0.005)。
- 两组HADS评分无统计学差异。
临床怎么用
- 对于桥本甲状腺炎甲减患者,可考虑手阳明经透刺作为改善症状和降低TGab的辅助治疗选择。
- 治疗期间需关注TGab、ThyPRO-39及SF-36等指标变化,TPOab与HADS改善不明显。
局限性
- 本研究为探索性试验,样本量有限,结论需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hashimoto's thyroiditis (HT) has a high incidence rate and unresolved clinical symptoms. Although Hand Yangming Meridian Penetrating Acupuncture has been used to treat thyroid diseases in China, there is no randomized controlled trial (RCT) on HT. METHODS: This exploratory RCT aims to preliminarily evaluate the efficacy, safety, and feasibility of Hand Yangming Meridian Penetrating Acupuncture in the treatment of HT. Included subjects were randomly assigned to the acupuncture group and the waiting treatment group at a ratio of 1:1. Subjects in the acupuncture group received 16 weeks of acupuncture treatment, followed by a 16-week follow-up observation phase. Subjects in the waiting group received thyroxine supplementation for 16 weeks, followed by 16 weeks of compensation treatment. Serum thyroid peroxidase antibody (TPOab) and thyroglobulin antibody (TGab) levels were the main indicators, and Thyroid-Related Patient-Reported Outcome short form (ThyPRO-39), MOS Item Short Form Health Survey (SF-36), and Hospital Anxiety and Depression Scale (HADS) scores were also recorded. RESULTS: In total, 58 subjects were included. After 16 weeks of treatment, there was no statistical difference in the changes in TPOab levels between the two groups, but the TGab level in the acupuncture group was significantly lower than in the waiting group (difference: -141.97 [95 % CI: -222.4 to -61.5], P = 0.011). Moreover, the total ThyPRO-39 and SF-36 scores were statistically different between the two groups (PThyPRO-39 < 0.001, PSF-36 = 0.005). There was no statistical difference in HADS between the two groups. CONCLUSIONS: Hand Yangming Meridian Penetrating Acupuncture may be safe and feasible for HT hypothyroidism to improve symptoms and reduce TGab levels. TRIAL REGISTRATION NUMBER: This trial was registered at Acupuncture-Moxibustion Clinical Trial Registry: AMCTR-IOR-19000308 (ChiCTR1900026830, https://www.chictr.org.cn/searchprojEN.html).
引用
- Wang S, Yang C, Zeng W, et al. Acupuncture treatment for Hashimoto's thyroiditis: An exploratory randomized controlled trial. Integr Med Res. 2024. PMID: 38420579. doi:10.1016/j.imr.2024.101023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。